NZ621083B2 - Composition for producing a temporary intestinal obstruction - Google Patents
Composition for producing a temporary intestinal obstruction Download PDFInfo
- Publication number
- NZ621083B2 NZ621083B2 NZ621083A NZ62108312A NZ621083B2 NZ 621083 B2 NZ621083 B2 NZ 621083B2 NZ 621083 A NZ621083 A NZ 621083A NZ 62108312 A NZ62108312 A NZ 62108312A NZ 621083 B2 NZ621083 B2 NZ 621083B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- suspension
- water
- composition
- dehydrating agent
- solid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 80
- 208000003243 Intestinal Obstruction Diseases 0.000 title description 2
- 239000000725 suspension Substances 0.000 claims abstract description 77
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 74
- 239000012024 dehydrating agents Substances 0.000 claims abstract description 65
- 239000007787 solid Substances 0.000 claims abstract description 65
- 229920002472 Starch Polymers 0.000 claims abstract description 33
- 210000000936 Intestines Anatomy 0.000 claims abstract description 32
- 239000008107 starch Substances 0.000 claims abstract description 32
- 235000019698 starch Nutrition 0.000 claims abstract description 32
- -1 chalk Substances 0.000 claims abstract description 16
- 150000004676 glycans Polymers 0.000 claims abstract description 15
- 229920000642 polymer Polymers 0.000 claims abstract description 15
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 15
- 239000005017 polysaccharide Substances 0.000 claims abstract description 15
- 150000004804 polysaccharides Polymers 0.000 claims abstract description 15
- 239000012046 mixed solvent Substances 0.000 claims abstract description 13
- 230000000968 intestinal Effects 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims abstract description 9
- 241000124008 Mammalia Species 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 229920002678 cellulose Polymers 0.000 claims abstract description 7
- 239000001913 cellulose Substances 0.000 claims abstract description 7
- 239000002734 clay mineral Substances 0.000 claims abstract description 6
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 6
- 229910003480 inorganic solid Inorganic materials 0.000 claims abstract description 6
- 239000004033 plastic Substances 0.000 claims abstract description 6
- 229920003023 plastic Polymers 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 239000011780 sodium chloride Substances 0.000 claims abstract description 6
- 239000006185 dispersion Substances 0.000 claims abstract description 5
- 239000011248 coating agent Substances 0.000 claims description 31
- 238000000576 coating method Methods 0.000 claims description 31
- 239000000463 material Substances 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 235000019868 cocoa butter Nutrition 0.000 claims description 6
- 229940110456 cocoa butter Drugs 0.000 claims description 6
- 229940116364 Hard Fat Drugs 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000155 melt Substances 0.000 claims description 2
- 230000002311 subsequent Effects 0.000 claims 1
- 239000000306 component Substances 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 235000019749 Dry matter Nutrition 0.000 description 9
- 238000002844 melting Methods 0.000 description 8
- 229920002261 Corn starch Polymers 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000008120 corn starch Substances 0.000 description 7
- 238000004062 sedimentation Methods 0.000 description 7
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 238000002161 passivation Methods 0.000 description 6
- 230000002522 swelling Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 5
- 229960005150 glycerol Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 4
- 238000007385 chemical modification Methods 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 description 3
- 208000005156 Dehydration Diseases 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920001983 poloxamer Polymers 0.000 description 3
- 229920001592 potato starch Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 241001147458 Dasheen mosaic virus Species 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229920003110 Primojel Polymers 0.000 description 2
- 206010053648 Vascular occlusion Diseases 0.000 description 2
- 238000005296 abrasive Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002475 laxative Effects 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 210000001367 Arteries Anatomy 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 240000007170 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N Maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229940100486 RICE STARCH Drugs 0.000 description 1
- 229940047670 SODIUM ACRYLATE Drugs 0.000 description 1
- 229920000247 Superabsorbent polymer Polymers 0.000 description 1
- 229940100445 WHEAT STARCH Drugs 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 230000035492 administration Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000008259 solid foam Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/04—Starch derivatives, e.g. crosslinked derivatives
- C08L3/08—Ethers
Abstract
Disclosed is a composition for forming a temporary intestinal occlusion in a mammal, said composition being flowable and solidifiable to form a solid plug at a predetermined site in the intestine, the structure of said plug being changeable to allow for a subsequent, at least partial removal of said occlusion, said composition being or comprising a flowable solution, suspension, or dispersion in a solvent or mixed solvent, wherein said composition comprises the following: a) a suspension of a solid in water or an aqueous mixed solvent, the suspension having a water content which exceeds the flow limit of the suspension; b) a dehydrating agent in an amount which is sufficient to bind water in an amount equal to the amount by which said water content of said suspension exceeds said flow limit of said suspension, so that, as a consequence of dehydration, the flow limit of the suspension is exceeded; and c) a means for passivating said dehydrating agent; wherein the suspended solid is selected from starch or cellulose-based polysaccharides, granular plastics, chalk, clay minerals and other inorganic solids, and wherein said dehydrating agent is selected from water-swellable polysaccharides, hygroscopic anhydrous inorganic salts, and water-absorbing polymers. occlusion, said composition being or comprising a flowable solution, suspension, or dispersion in a solvent or mixed solvent, wherein said composition comprises the following: a) a suspension of a solid in water or an aqueous mixed solvent, the suspension having a water content which exceeds the flow limit of the suspension; b) a dehydrating agent in an amount which is sufficient to bind water in an amount equal to the amount by which said water content of said suspension exceeds said flow limit of said suspension, so that, as a consequence of dehydration, the flow limit of the suspension is exceeded; and c) a means for passivating said dehydrating agent; wherein the suspended solid is selected from starch or cellulose-based polysaccharides, granular plastics, chalk, clay minerals and other inorganic solids, and wherein said dehydrating agent is selected from water-swellable polysaccharides, hygroscopic anhydrous inorganic salts, and water-absorbing polymers.
Description
Composition for producing a temporary intestinal obstruction
The present invention relates to the field of medical endoscopy and endo-surgery,
and, more specifically, the field of enteroscopy and entero-surgery.
For many years, endoscopy has been a well-established diagnostic procedure used
in human and veterinary medicine. The endoscopes used for this procedure have
been undergoing continuous development, and today they do not only allow for the
simple illumination or imaging of the interior of the body, e.g. by using optical fibers,
but are also equipped for performing minimally invasive surgery. Apart from fiber
optics, modern endoscopes comprise, for example, air insufflators or gas pumps,
irrigators, aspiration pumps, as well as flexible tools such as cannulae for injections,
gripping or cutting tools, or wire electrodes for achieving coagulation by means of
electrical current. The endoscope has several channels for introducing the medical
tools required for the respective surgical intervention.
Especially in the case of enteroscopic surgical interventions in the intestines of
human beings and animals, complications often occur due to feces passing the locat-
ion which is to be examined and/or to be treated surgically, in spite of previous
administrations of laxatives, which does not only make the procedure more difficult
and lengthier, but, in the case of surgical interventions, e.g. for obtaining tissue
samples or removing tissue, also constitutes a risk of infection for the patient. Thus, it
would be desirable to make it possible to seal the intestine for the duration of entero-
scopic surgery.
In literature, several solutions for this task can be found. While the main claim of
generally covers the formation of a polymer plug "at a site in a
mammal" by letting a viscous polymeric composition solidify at body temperature, the
only purpose of this application, as described in the rest of the application, consists in
the closure of arteries, i.e. in hemostasis. The disclosure therein is based on reverse-
ly thermosensitive polymers, i.e. on polymers which are water-soluble at room temp-
erature but precipitate from the solution at body temperature. Examples include
poloxamers such as those marketed by BASF under the trade name Pluronics .
Further examples can be found in A2 and US 2008/215036 A1,
which also describe poloxamers. A2 describes compositions
containing copolymers of hydroxy fatty acids, which increase their viscosities when
contacted with physiological fluids, for tissue repair purposes. And WO 96/22789 A1
discloses biocompatible polymers selected from alginate, chitosan, and poly(L-amino
acids) for occluding vessels.
These embodiments, however, have the disadvantage that it is difficult to transport
the respective composition to the desired occlusion site within the intestine and to
prevent them from at least partially flowing off before a plug has been formed. If the
plug is to be formed by swelling, as described in WO 96/22789 A1, for example, it is
necessary to pump a relatively large amount of liquid into the intestine, which makes
it even more likely that the composition flows off from the desired site of use.
In addition, mechanisms which work in blood vessels, where the respective composit-
ions come into contact with relatively large quantities of liquid, i.e. blood, to achieve a
fast change of temperature or viscosity, do not work in the same way in the intestine:
prior to intestinal surgery, patients are usually administered laxatives, which means
that the composition only comes into contact with small amounts of liquid adhering to
the intestinal wall.
Therefore, it was an aim of the present invention to provide a composition with which
the above-mentioned disadvantages can be overcome; and/or which at least
provides the public with a useful choice.
In this specification where reference has been made to patent specifications, other
external documents, or other sources of information, this is generally for the purpose
of providing a context for discussing the features of the invention. Unless specifically
stated otherwise, reference to such external documents is not to be construed as an
admission that such documents, or such sources of information, in any jurisdiction,
are prior art, or form part of the common general knowledge in the art.
In the description in this specification reference may be made to subject matter that is
not within the scope of the claims of the current application. That subject matter
should be readily identifiable by a person skilled in the art and may assist in putting
into practice the invention as defined in the claims of this application.
SUMMARY OF THE INVENTION
In a first aspect, the invention provides a composition for forming a temporary
intestinal occlusion in a mammal, said composition being flowable and solidifiable to
form a solid plug at a predetermined site in the intestine, the structure of said plug
being changeable to allow for a subsequent, at least partial removal of said
occlusion, said composition being or comprising a flowable solution, suspension, or
dispersion in a solvent or mixed solvent,
wherein said composition comprises the following:
a) a suspension of a solid in water or an aqueous mixed solvent, the suspens-
ion having a water content which exceeds the flow limit of the suspension;
b) a dehydrating agent in an amount which is sufficient to bind water in an
amount equal to the amount by which said water content of said suspension exceeds
said flow limit of said suspension, so that, as a consequence of dehydration, the flow
limit of the suspension is exceeded; and
c) a means for passivating said dehydrating agent.;
wherein the suspended solid is selected from starch- or cellulose-based polysacchar-
ides, granular plastics, chalk, clay minerals and other inorganic solids,
and wherein said dehydrating agent is selected from water-swellable polysaccharid-
es, hygroscopic anhydrous inorganic salts, and water-absorbing polymers.
In a second aspect, the invention relates to a use of a composition of the invention, in
the manufacture of a solid, changeable plug, to form a temporary intestinal occlusion
in a mammal.
DISCLOSURE OF THE INVENTION
The term “comprising” as used in this specification means “consisting at least in part
of”. When interpreting each statement in this specification that includes the term
“comprising”, features other than that or those prefaced by the term may also be
present. Related terms such as “comprise” and “comprises” are to be interpreted in
the same manner.
The aim of the invention is achieved by providing a composition for forming a
temporary intestinal occlusion in a mammal, said composition being flowable and
solidifiable to form a solid plug at a predetermined site in the intestine, the structure
of said plug being changeable to allow for a subsequent, at least partial removal of
said occlusion, said composition being or comprising a flowable solution, suspension,
or dispersion in a solvent or mixed solvent,
wherein said composition comprises the following:
a) a suspension of a solid in water or an aqueous mixed solvent, the suspens-
ion having a water content which exceeds the flow limit of the suspension;
b) a dehydrating agent in an amount which is sufficient to bind water in an
amount equal to the amount by which said water content of said suspension exceeds
said flow limit of said suspension, so that, as a consequence of dehydration, the flow
limit of the suspension is exceeded; and
c) a means for passivating said dehydrating agent.;
wherein the suspended solid is selected from starch- or cellulose-based polysacchar-
ides, granular plastics, chalk, clay minerals and other inorganic solids,
and wherein said dehydrating agent is selected from water-swellable polysaccharid-
es, hygroscopic anhydrous inorganic salts, and water-absorbing polymers.
In some instances the amount of water is described herein as exceeding the flow
limit of the suspension by an amount X.
Such a composition can be used to create a solid plug of the sedimented solid at the
desired site in the intestine by removing or deactivating the passivation of the
dehydrating agent. The latter then binds at least the amount (in one embodiment X)
of water which exceeds the flow limit of the suspension of the solid, which results in
the solid's sedimentation and solidification and, thus, to an occlusion of the intestine.
The principle of the plug formation is not, or not primarily, based on swelling or
gelling the solid itself, but relies on a completely different mechanism, namely
sedimentation. While, depending on the type of the dehydrating agent, the dehydrat-
ion may be effected by swelling, as described below, this does not necessarily have
to be the case. This means that the total liquid content of the composition may be
lower than in most compositions according to the state of the art.
Herein, "suspension" refers to a stable, not spontaneously sedimenting mixture of a
solid and water, which, depending on the particle size of the suspended solid, may
contain suspending aids. The particle size of the solid in the suspension is not specif-
ically limited and may even be as low as colloidal dimensions, in which case a
suspending aid will mostly not be required.
In addition to water, the solvent of the suspension may contain one or several physio-
logically acceptable organic solvents, which means that it may be an aqueous mixed
solvent. Examples of suitable organic solvents include alcohols and glycols, e.g. glyc-
erol or poly(ethylene glycol), ethers, e.g. glycol ethers, and esters, e.g. glycol esters.
In preferred embodiments, the solid concentration of the aqueous suspension is
selected to be not more than 5 %, more preferably not more than 3 % and even more
preferably not more than 1 % below the flow limit, so that, firstly, only a very low
amount of the dehydrating agent and, secondly, a very short period of time are
required for solidifying the composition into a plug. Therefore, solidification is
accomplished very fast, before the composition flows off from the delivery site. The
amount X of water exceeding the flow limit preferably only amounts to a few grams or
to only 1 gram or less. In some embodiments, the amount (in one embodiment X) will
depend on the distance between the application site and the anus, as will be
discussed in more detail below.
The suspended solid is not specifically limited, as long as it is capable of forming a
suspension with water or an aqueous solvent, which suspension will solidify by sedi-
mentation at a defined concentration. Possible solids include, for example, various
natural and artificial polymers such as polysaccharides, granular plastics and mixtur-
es thereof, but also inorganic solids such as mineral solids, especially soft, non-
abrasive, fine powders, e.g. chalk and clay minerals. A "solid" herein also refers to a
mixture of two or more solids showing corresponding effects.
The suspended solid preferably is or comprises a polysaccharide, more preferably a
starch- or cellulose-based polysaccharide, as they are inexpensive and innocuous for
the body and form suspensions the characteristics of which can be well controlled.
Starch which is not cold-soluble, e.g. granular, native potato starch, tapioca starch,
corn starch, wheat starch, or rice starch, is particularly preferred as the solid, as
these fine, spherical, non-abrasive natural substances have clearly defined flow limits
and, in addition to the above mentioned advantages, are inexpensive and physio-
logically acceptable.
The dehydrating agent is not subject to any specific limitations and its functions may
rely on different physical or chemical mechanisms. The water may, for example, be
bound by chemical reactions, e.g. by spontaneous hydrolysis of instable bonds such
as ortho-esters or acetals, to which end the suspension and/or the dehydrating agent
may contain further reaction partners such as catalysts, e.g. a weak acid or base.
These reaction partners should also be innocuous and physiologically acceptable,
just like the thus formed reaction products and, in general, all components of the
inventive composition. Further examples of water-binding reactions include hydration
and swelling of solids, preferably hygroscopic solids; for these reactions, for example,
sodium sulfate and other anhydrous inorganic salts as well as organic polymers,
which will be discussed in further detail below, may be used.
The dehydrating agent b) may also be a solid tablet or the like which may be trans-
ported to the site of use by means of the gripping tool of the endoscope, for example,
whereafter the suspension a) is injected onto said tablet via an endoscope channel,
which leads to the sedimentation of the solid and, optionally, swelling of the dehydrat-
ing agent, so that the plug is formed (see below).
In theory, also a combination of one of the above defined solid suspensions and a
mechanically acting dehydrating agent may be used for the purpose of the present
invention; it is, for example, possible to use a dehydrating sponge or a ceramic or
glass frit, which, again, are separately transported to the desired site in the intestine
and contacted there. The passivation is achieved by said separate delivery to the site
of use. However, as such solutions of the task of the invention are more
cumbersome, they are not preferred.
The dehydrating agent preferably is or comprises a polymer which is swellable in
water and which, for example, may be selected from polymers used as disintegration
aids or tablet disintegrants, e.g. starch or cellulose or derivatives thereof, alginates,
dextrans, cross-linked poly(vinylpyrrolidone), etc. Other examples include so called
superabsorbent polymers, i.e. highly water-absorbing polymers, used for various
sanitary articles, for example, and including polymers based on acrylonitril, acrylic
acid, acrylamide, or poly(vinyl alcohol), such as polyacrylate/polyacrylamide,
ethylene/maleic anhydride or acrylic acid/sodium acrylate copolymers, cross-linked
poly(ethylene oxide), etc. More preferably, the dehydrating agent is a polysaccharide,
even more preferably starch, particularly sodium carboxymethyl starch, which, again,
are innocuous and very inexpensive.
Moreover, upon swelling, the volume of such a starch-based dehydrating agent
increases significantly, which leads to an increase of the volume of the plug, which
mainly consists of the sedimented solid, even if the ratio of the amounts of the solid
suspension and the dehydrating agent is very high; consequently, the plug may
easily fill and thus occlude the intestinal lumen. Therefore, it is, again, possible to
keep the total amount of liquid in the composition low.
The amount of dehydrating agent used in the composition of the invention is directly
related to the concentration of the suspended polymer amount and the suspension's
flow limit. At any rate, the amount has to be sufficient to bind the amount of water
exceeding the concentration at the flow limit. In one embodiment it is sufficient to
bind the amount X of water exceeding the concentration at the flow limit. Preferably,
it is sufficient to bind 1%, more preferably between 1 and 10%, even more preferably
between 1 and 5%, and even more preferably between 1 and 3%, of the water
contained in the composition.
The amount of heat usually liberated upon binding the water also has to be taken into
consideration, as the solidifying composition should not be excessively heated.
However, one may also make specific use of this amount of heat, as will be describ-
ed in further detail below.
In some preferred embodiments of the invention, at least a portion of the dehydrating
agent at the same time constitutes at least a portion of the suspended solid, as will
be described in further detail below.
The type of the means for passivating the dehydrating agent is not subject to any
specific limitations, as long as it efficiently prevents the dehydrating agent from react-
ing with the water contained in the suspension. The passivation may, for example, be
removed or deactivated only immediately before use of the composition or even only
in the intestine. The passivating means may, for example, consist in a chemical
modification of the dehydrating agent, e.g. a protecting group, which has to be
removed to activate the dehydrating agent and enable it to react with water. A swell-
able polysaccharide may, for example, be modified with hydrophobic groups which
prevent water from accessing the polysaccharide before they are eliminated.
If the dehydrating action of the agent is based on a chemical reaction with water, the
passivating means should be deactivatable at least as fast as the activated dehydrat-
ing agent reacts with water. The passivated dehydrating agent may be reacted with
an additional reactant contained in the suspension, e.g. an acid or a base, in order to
be activated.
In preferred embodiments, however, the passivating means is not a chemical modif-
ication, but a coating covering the dehydrating agent, which has to be removed for
said agent to be activated. It may, for example, be a water-soluble and/or hydrolyz-
able coating which gradually dissolves when contacted with the aqueous suspension
and thus liberates the dehydrating agent. In such cases, the composition preferably
is a two-component system, which is only mixed immediately before its use. The heat
of solution generated by exothermic solvation and the heating of the composition
while being transported through the endoscope channel both accelerate the
dissolution of the coating. In addition, the molecules of the coating being dissolved
already bind a portion of the water, so that the suspension of the polymer already
approaches its flow limit, even before the dehydrating agent is activated. In these
cases, the coating, serving as the passivating means, itself also serves as a
dehydrating agent of the present invention.
In particularly preferred embodiments, the coating consists of a material which melts
at the temperatures prevailing in the intestine; in this context, again, the heating
occurring in the endoscope has to be taken into consideration. Particularly if the
intended site of the occlusion is far away from the anus, the introduction of the endo-
scope takes a long time, up to half an hour, for example. As the temperatures in the
intestine normally amount to about 37 °C, the endoscope may be heated to over
°C in the course of its introduction, e.g. to approx. 35 °C. For this reason, it is
preferred to use a material as the coating material which does not melt at temperatur-
es below 35 °C, more preferably not below 35.5 °C, even more preferably not below
36 °C, even more preferably not below 36.5 °C, and, in special cases, even not
below approx. 37 °C.
The coating material is preferably selected from natural or synthetic waxes and fats,
natural waxes and fats being particularly preferred according to the invention as they
are well tolerated and their effects are known. Materials which are used for coating
suppositories are particularly preferred, e.g. hardened fat having a melting range
close to human body temperatures. Examples include hardened fat obtained from
palm kernel and coconut fats, consisting mainly of lauric acid, the melting point of
which may be precisely controlled by controlling the degree of a subsequent ester-
ification using glycerol, i.e. by controlling the hydroxyl number of the ester thus obtain-
ed. Cocoa butter which may have melting ranges between 30 and 38 °C is another
preferred example, even more preferably cocoa butter in the β-modification. Hard fat
is particularly preferred, as its melting point can be precisely controlled.
In general, the melting point of the respective coating may also be finely adjusted by
the average artisan without undue experimentation by producing mixtures of the
above mentioned substances with suitable waxes, fats or resins having higher melt-
ing points.
If the coating thickness is adequately selected, a complete melting of the coating
and, thus, an exposition of the dehydrating agent during its transport through the
heated endoscope channel can be prevented. Under suitable pressure conditions,
the composition will pass through the endoscope within a few seconds' time, so that
a sufficiently thick coating will not have been completely molten. The same principle
applies for a water-soluble coating.
Therefore, the coating should be sufficiently thick in order to guarantee a safe trans-
port through the endoscope channel, while, at the same time, allowing for a fast
removal within the intestine.
Depending on the way in which the dehydrating agent is passivated, it may also be
suspended in the suspension of the solid or it may be vortexed in the composition of
the invention right before its use and then be immediately pumped through the endo-
scope channel. The suspension of the solid and the dehydrating agent then prefer-
ably form a suspension which is stable at least for a few minutes, in order to allow for
its homogeneous distribution, which is why dehydrating agents having a very small
particle size are preferred as is the use of a well-suspendable coating material, if a
passivation by means of a coating is provided.
In particularly preferred embodiments, at least a portion of the suspended solid at the
same time constitutes at least a portion of the dehydrating agent, as has already
been mentioned above. This means that the suspended solid, or a portion thereof, is
capable of binding water on its part, as soon as the passivation has been removed.
The means for passivating the dehydrating agent may again consist in a coating or a
chemical modification of the latter, as described above. However, in these embodi-
ments of the invention, the passivating means preferably consists in a spatially
separate provision of the water and the dehydrating agent, in which case they are
only mixed in the intestine or immediately prior to delivering the inventive composition
into the intestine.
In such embodiments, before use, the composition preferably is a two-component
system, comprising a dehydrating agent in a physiologically acceptable solvent,
which is preferably essentially anhydrous, but sufficiently water-miscible, as a first
component and water or an aqueous mixture as a second component. The two com-
ponents are mixed immediately before or during their use, thus forming a suspension
of the solid serving as a dehydrating agent in a mixed solvent, which also contains
water; at the beginning, the water content of said suspension exceeds the flow limit
(in one embodiment by the amount X), but gradually approaches said flow limit as a
consequence of the reaction of the dehydrating agent, and reaches it after having
bound the amount (in one embodiment X) of water, whereupon, again, the solid is
sedimented.
Particularly if the two components of the two-component system are mixed outside
the intestine, which is preferred according to the invention, as only one channel of the
endoscope is needed for supplying the composition of the invention to the site of use,
the ratio of the components' amounts have to be determined very precisely as a
function of the distance between the site of use and the anus. The mixed compon-
ents have to be transported to the site of use faster than the amount X of water is
bound by the dehydrating agent, in order to prevent sedimentation within the endo-
scope channel. A specific example of such an embodiment will be described in the
exemplary embodiments below.
Alternatively, the two components may also be mixed at the site of use, as mentioned
above, which either requires two separate endoscope channels or rendering the
suspension thixotropic, in order to prevent it from flowing off from the site of use
before being contacted with water. It is also possible to passivate a portion of the
solid serving as dehydrating agent by coating or chemical modification, in addition to
the spatial separation, said coating or modification being then only inactivated within
the intestine, for example by melting.
In addition to the above defined components, a composition of the invention may, of
course, also comprise any other components, as long as they do not interfere with
the invention's mode of action. Examples include suspension aids, viscosity regulat-
ors, surfactants, or binding agents in order to improve the plug's adherence to the
intestinal wall, derivatives of natural resins, casein, and other animal proteins, for
example. Some embodiments of the composition of the invention may further contain
foaming agents and foam stabilizers, as the plug may consist of a solid foam in some
cases. For this purpose, granules, consisting of the dehydrating agent and one or
more foaming agents, may be covered by a wax or similar coating, so that these
agents are activated when the coating is molten or dissolved.
Also described is a method for forming a temporary intestinal occlusion in a mammal
using the composition according to the first aspect of the invention, said method
comprising:
i) delivering the composition to a predetermined site in the intestine;
ii) removing or deactivating the passivation of the dehydrating agent in order to cause
sedimentation to occur and thus solidify the composition at this site to form a solid
plug occluding the intestine; and, optionally,
iii) changing the structure of the plug in order to at least partially remove the occlus-
ion;
wherein step iii) may be omitted, if the structure of the plug in the intestine changes
of its own volition in the course of time, i.e. without any interference, and the occlus-
ion is at least partially removed this way.
In preferred embodiments of the method, in order to at least partially remove the
occlusion, step iii) comprises the supply of additional water to the plug to liquefy it
again by lowering the concentration below the flow limit, so that the plug's
components may flow off from the site of use.
A possible general approach for producing a composition according to the first aspect
of the invention and particularly for determining the proportion of the components is
described in a specific, relatively simple example. The average artisan will first select
component a), choosing corn starch (as in the exemplary embodiments 1 and 2), for
example. The flow limit of a suspension of the available starch powder batch is
determined in simple preliminary tests, for example by adding portions of the starch
powder to a stirred body of water having a known weight, e.g. adding portions of 0.5
g of starch to 100 g of water. Using corn starch, a value of approx. 42 % by weight
will be obtained as the flow limit of the aqueous suspension.
Then the average artisan will select a dehydrating agent, e.g. sodium carboxymethyl
starch, and determine the amount of water bound by the agent per weight unit, for
example by adding 1 g of the dehydrating agent to 10 ml of water, stirring the water
for a short time and then filtering the agent off again and weighing the residual water.
The water absorption capacity of the agent will, for example, be determined to
amount to approx. 5 g per 1 g carboxymethyl starch.
After that, the average artisan could decide to use a 40 % by weight suspension of
corn starch in water (i.e. 40 g of starch in 60 g of water) as the solid suspension of
the inventive composition. In order to increase the starch concentration from 40 to
42 % and thus exceed the flow limit, causing sedimentation of the starch, the
dehydrating agent has to bind approx. 5 g of water, since 40 g of starch in 55 g of
water correspond to 42.1 % by weight.
This means that the amount of dehydrating agent to be added corresponds to the
amount capable of binding 5 g of water, which, according to the above-mentioned
determination, is 1 g carboxymethyl starch.
Accordingly, the amount X in this example would be 5 g of water, and the required
minimum amount of component b) would be 1 g of carboxymethyl starch.
In the following, the present invention will now be described with reference to specific
exemplary embodiments.
EXAMPLES
Example 1
To an aqueous 40% suspension (based on dry matter) of native corn starch, 3 % by
weight, based on the starch dry matter, of a granular sodium carboxymethyl starch,
as commercially available as Primojel from DMV Fronterra or Ultramyl from Gustav
Parmentier, for example, were added after having been passivated by means of a
cocoa butter coating. When the suspension thus prepared was heated to 37 °C, it
started to solidify at approx. 35 °C to form a solid sediment which had entirely lost its
flowability. When water was added, the solid sediment quickly regained its flowability
when reaching a concentration below 35 %.
Example 2
To an aqueous 40% suspension (based on dry matter) of native corn starch, 3 % by
weight, based on the starch dry matter, of a granular sodium carboxymethyl starch,
which had been passivated by applying a coating of hard fat, were added.
Additionally, 1 % by weight, based on the starch dry matter, of a suspension stabiliz-
er, namely of cold-soluble, swellable corn starch, was stirred into the suspension.
When stored below 30 °C, the suspension did not tend to form a sediment. When the
suspension was heated to 37 °C, it started to solidify at approx. 36 °C to form a solid
sediment which had entirely lost its flowability. When water was added, the solid
sediment quickly regained its flowability when reaching a concentration below 35 %.
Example 3
To an aqueous 38 % suspension (based on dry matter) of native potato starch, 3 %
by weight, based on the starch dry matter, of a granular sodium carboxymethyl starch,
which had been passivated by applying a coating of cocoa butter, were added. When
the suspension was heated to 37 °C, it started to solidify at approx. 35 °C to form a
solid sediment which had entirely lost its flowability. When water was added, the solid
sediment quickly regained its flowability when reaching a concentration below 35 %.
Example 4
An aqueous 38 % suspension (based on dry matter) of native potato starch was stir-
red at 50 °C for 30 minutes and then cooled to 25 °C. Then 3 % by weight, based on
the starch dry matter, of a granular sodium carboxymethyl starch, which had been
passivated by applying a coating of cocoa butter, were added. When stored below
°C, the suspension did not tend to form a sediment. When the suspension was
heated to 37 °C, it started to solidify at approx. 35 °C to form a solid sediment which
had entirely lost its flowability. When water was added, the solid sediment quickly
regained its flowability when reaching a concentration below 33 %.
Example 5
Via a cannula, the suspension of Example 1 was introduced into an artificial segment
of porcine intestine which was stored at 37 °C. A solid sediment formed within a short
time, completely occluding the segment of the intestine. After 30 minutes, the solid
sediment could easily be removed from the segment of the intestine by rinsing with
water.
Example 6
100 ml of a suspension of granular sodium carboxymethyl starch, as commercially
available as Primojel from DMV Fronterra or Ultramyl from Gustav Parmentier, for
example, in glycerol, having a viscosity of approx. 1,500 mPa.s is used as compon-
ent 1 of a two-component system and pumped into a Y-shaped piece via a tubing.
Said sodium carboxymethyl starch serves both as suspended solid and as dehydrat-
ing agent. 20 ml of water, serving as component 2, are also pumped into said Y-
shaped piece via another tubing. Thus, the means for passivating the dehydrating
agent consists, on the one hand, in the spatial separation of the two components of
the inventive composition, i.e. of the dehydrating agent and the water, and, on the
other hand, in the suspension of the former in glycerol which has to mix with the
water at first, in order to enable the inventive composition to become effective.
The components 1 and 2 are mixed in the Y-shaped piece, the viscosity of the
mixture being significantly lower than that of the glycerol suspension, amounting to
approx. 200 mPa.s. This low-viscosity mixture is delivered to the desired site in the
intestine within a few seconds' time via the working channel of an endoscope. Within
seconds after mixing the two components, the viscosity of the mixture increases
very fast as the granules absorb water, whereby the mixture solidifies to form a solid
sediment consisting of carboxymethyl starch granules which have greatly expanded
due to the water absorption. This sediment forms a plug, which completely occludes
the respective segment of the intestine. By simply adding a sufficient amount of
water, the solid sediment is liquefied again after the examination has been complet-
ed, so that the occlusion is removed.
Thus, the present invention provides compositions for occluding the intestine of a
patient in a simple, inexpensive and physiologically innocuous way, in order to be
able to carry out medical interventions.
Claims (14)
1. A composition for forming a temporary intestinal occlusion in a mammal, said composition being flowable and solidifiable to form a solid plug at a predetermined site in the intestine, the structure of said plug being changeable to allow for a sub- sequent, at least partial removal of said occlusion, said composition being or com- prising a flowable solution, suspension, or dispersion in a solvent or mixed solvent, wherein said composition comprises the following: a) a suspension of a solid in water or an aqueous mixed solvent, the suspens- ion having a water content which exceeds the flow limit of the suspension; b) a dehydrating agent in an amount which is sufficient to bind water in an amount equal to the amount by which said water content of said suspension exceeds said flow limit of said suspension, so that, as a consequence of dehydration, the flow limit of the suspension is exceeded; and c) a means for passivating said dehydrating agent.; wherein the suspended solid is selected from starch- or cellulose-based polysacchar- ides, granular plastics, chalk, clay minerals and other inorganic solids, and wherein said dehydrating agent is selected from water-swellable polysaccharid- es, hygroscopic anhydrous inorganic salts, and water-absorbing polymers.
2. The composition according to claim 1, wherein the suspended solid is or comprises granular native starch.
3. The composition according to claim 1, wherein the dehydrating agent is or comprises a water-swellable polysaccharide.
4. The composition according to claim 3, wherein said water-swellable polysaccharide is sodium carboxymethyl starch.
5. The composition according to claim 1, wherein at least a portion of the suspended solid at the same time constitutes at least a portion of the dehydrating agent.
6. The composition according to claim 5, wherein, before its use in the intestine, the composition is a two-component system which contains i) as a first component, the solid which at the same time acts as dehydrating agent, suspended in a physiologically acceptable solvent or mixed solvent, and ii) as a second component, water or an aqueous mixture, the separation of dehydrating agent and water before the composition's use in the intestine constituting the means c) for passivating the dehydrating agent.
7. The composition according to claim 1, wherein the passivating means consists in a coating covering said dehydrating agent.
8. The composition according to claim 7, wherein the coating consists of a material which melts at the temperatures prevailing in the intestine.
9. The composition according to claim 8, wherein the coating material does not melt at temperatures below 35 °C.
10. The composition according to claim 9, wherein the coating material does not melt at temperatures below 36 °C.
11. The composition according to claim 7, wherein the coating material is selected from hard fat and cocoa butter.
12. Use of a composition as claimed in any one of claims 1 to 12, in the manufacture of a solid, changeable plug, to form a temporary intestinal occlusion in a mammal.
13. A composition as claimed in any one of claims 1 to 11, substantially as herein described with reference to any example thereof.
14. Use as claimed in claim 12, substantially as herein described with reference to any example thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ATA1026/2011A AT511671A1 (en) | 2011-07-13 | 2011-07-13 | COMPOSITION FOR GENERATING TEMPORARY OCCLUSION OF THE IMMUNE OF AN IMAGE AGENT |
ATA1026/2011 | 2011-07-13 | ||
PCT/AT2012/050102 WO2013006886A2 (en) | 2011-07-13 | 2012-07-12 | Composition for producing a temporary intestinal obstruction |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ621083A NZ621083A (en) | 2016-04-29 |
NZ621083B2 true NZ621083B2 (en) | 2016-08-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6893074B2 (en) | Reagents used for repair or hemostasis of biological tissue damage and their applications | |
JP5148030B2 (en) | Novel high viscosity embolization composition | |
JP6759335B2 (en) | Carboxymethyl chitosan sponge formulation | |
JP2001509133A (en) | Compositions for use in occluded vessels | |
US20160038599A1 (en) | Biocompatible in situ Hydrogel | |
Lord et al. | Advancements in the development on new liquid embolic agents for use in therapeutic embolisation | |
CN105462142B (en) | A kind of temperature sensitive type interpenetration network hydrogel material and its preparation method and application | |
JP2002504400A (en) | Gynecological embolization method | |
JP2009213899A (en) | Method for embolizing blood vessel | |
JP2008517899A (en) | Fillable polyphosphazene-containing particles for therapeutic and / or diagnostic applications and methods for their preparation and use | |
JP2003502131A (en) | Method for embolizing a vascular site using an embolizing composition | |
WO2004035093A2 (en) | Polymeric materials for site specific delivery to the body | |
CN116333348A (en) | Compositions and methods relating to occlusive polymer hydrogels | |
CA2844501C (en) | Composition for forming a temporary intestinal occlusion in a mammal | |
CN110215542A (en) | A method of forming the interim obturator of blood vessel | |
CN100453125C (en) | Non-viscous medical use liquid embolic agent | |
CN110214033A (en) | Agaroid structure and relevant use and preparation method | |
JP5641699B2 (en) | Process for producing pearl-like polyvinyl alcohol particles and temporary embolic agent for blood vessel | |
JP5121172B2 (en) | Temporary embolic material, method for producing the same, and temporary embolic agent | |
WO2007004484A1 (en) | Pva particle for use in temporary embolization of blood vessel, process for production thereof, and temporary embolizing agent for blood vessel | |
NZ621083B2 (en) | Composition for producing a temporary intestinal obstruction | |
ES2671907T3 (en) | Composition for the generation of a temporary intestinal occlusion | |
KR101632430B1 (en) | Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics | |
US20110177021A1 (en) | Composition for forming a temporary obstruction and method of forming the same | |
CN116747345A (en) | Novel vascular embolism agent and preparation method thereof |